Subscribe to Search results

NBTS directors discussed whether to discontinue collecting blood from prisons in England and Wales.

Published on:

Dr Henry Yellowlees, CMO, wrote to all regional medical officers in England advising that collection of blood from prisons could continue.

Published on:

The International Society of Blood Transfusion advised against collecting blood from prisoners.

Published on:

DHSS issued a circular advising that donors with a history of jaundice could donate provided they had not exhibited symptoms over the previous 12 months and had a negative HBsAg test.

Published on:

DHSS issued a circular advising on record-keeping and stock control arrangements.

Published on:

AIDS was discussed at the regular meeting of Regional Transfusion Directors.

Published on:

The first NBTS leaflet on AIDS and how it concerned blood donors was published.

Published on:

The collection of blood from prisons ceased in Scotland.

Published on:

The collection of blood from closed prisons was stopped in England and Wales.

Published on:

The second NBTS leaflet on AIDS containing advice for blood donors was published.

Published on:

Long-term review (A Full Life; Not Just Existence) commissioned by the Macfarlane Trust suggested approaching the Department of Health for further funding.

Published on:

Dr Duncan Thomas inspected Hyland Laboratories in California noting a hepatitis hazard associated with the products as a result of the nature of the donors and the large plasma pools.

Published on:

CSM(B) recommended the grant of a product licence for Hemofil.

Published on:

CSM(B) recommended the grant of a product licence for Kryobulin.

Published on:

A product licence was granted for Profilate made by Abbott Laboratories Ltd.

Published on:

CSM(B) recommended a product license be granted for Factor 8.

Published on:

DHSS Divisional Management Group meeting considered criticisms made by the documentary World in Action: Blood Money of Travenol's production of Factor 8.

Published on:

Dr David Owen considered Armour's application to supply Factorate to haemophilia centres.

Published on:

CSM recommended the grant of a product licence for Koate.

Published on:

An application was made by Immuno to vary the product licence in respect of Kryobulin to allow European plasma to be sold in red packs and US plasma to be sold in cheaper blue packs.

Published on: